{"url_path":"/sec/evfm/8-k/2026-07-20/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1618835/0001493152-26-033910-index.html","accession_number":"0001493152-26-033910","cik":"0001618835","ticker":"EVFM","issuer_name":"Evofem Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1618835/0001493152-26-033910-index.html","primary_entity_key":"0001618835","primary_entity_name":"Evofem Biosciences, Inc."},"word_count":79,"has_tables":true,"body_markdown":"**Item\n9.01.**\n**Financial\nStatements and Exhibits.**\n\n \n\n(d)\nExhibits\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n \n \n \n\n99.1\n \n[Corporate presentation prepared as of July 20, 2026](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**EVOFEM\nBIOSCIENCES, INC.**\n\n \n \n \n\nDated:\nJuly 20, 2026\nBy:\n*/s/\nSaundra Pelletier*\n\n \n \nSaundra\nPelletier\n\n \n \nChief\nExecutive Officer"}